Executing a successful presidential transition requires serious planning, said Max Stier, president and CEO of the ...

Two prominent supporters of President-elect Trump’s campaign have emerged as the frontrunners to lead the Treasury Department ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 1.73% of ...

The company’s project-by-project approach has resulted in gains for investors over the years and the trend is continuing in ...

Several pure-play space stocks rallied 20% or more this week, in part driven by what sector analysts say is a “Trump-Elon trade.” ...

Howard Lutnick, President-elect Trump’s adviser, is CEO of Cantor Fitzgerald, which lost hundreds of employees on 9/11.

Cantor Fitzgerald tells investors that MariTide’s Phase 1 data includes “a big surprise” as the supplemental appendix file ...

(Reuters) -Amgen said on Wednesday there was no link between its experimental weight-loss drug and changes in bone density, a ...

Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) – Equities researchers at Cantor Fitzgerald boosted their FY2024 earnings estimates for Vaxcyte in a report released on Wednesday, November 6th.

Fintel reports that on November 14, 2024, Cantor Fitzgerald downgraded their outlook for Innoviz Technologies (NasdaqCM:INVZ) ...